Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hyaluronidase Via Laser-Assisted Drug Delivery for the Treatment of Scleroderma-induced Microstomia

NCT05995626 is registered in ClinicalTrials.gov with University of Nebraska as lead sponsor.

NCT NCT05995626
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05995626 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hyaluronidase Via Laser-Assisted Drug Delivery for the Treatment of Scleroderma-induced Microstomia
Lead sponsor
University of Nebraska
Phase
Phase 1
Overall status
Completed
Start date
March 1, 2024
Completion date
September 24, 2024
Enrollment
3 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

microstomia, scleroderma